Towards the development of an epitope-focused vaccine for SARS-CoV-2.

ABSTRACT: The rapid spread of COVID-19 on all continents and the mortality induced by SARS-CoV-2 virus, the cause of the pandemic coronavirus disease 2019 (COVID-19) has motivated an unprecedented effort for vaccine development. Inactivated viruses as well as vaccines focused on the partial or total sequence of the Spike protein using different novel platforms such us RNA, DNA, proteins, and non-replicating viral vectors have been developed. The high global need for vaccines, now and in the future, and the emergence of new variants of concern still requires development of accessible vaccines that can be adapted according to the most prevalent variants in the respective regions. Here, we describe the immunogenic properties of a group of theoretically predicted RBD peptides to be used as the first ste

SUBMITTER: Cervantes-Torres J 

PROVIDER: S-EPMC9513333 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature